Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers

Cellular Oncology

Volumn 38, Issue 6, 2015, Pages 433-442

  Fkih M’hamed, Insaf ^a,b,c   Privat, Maud ^a,b   Ponelle, Flora ^a,b   Penault Llorca, Frédérique ^b   Kenani, Abderraouf ^c   Bignon, Yves Jean ^a,b  

^a CENTRE JEAN PERRIN   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

BRCA1; Human triple negative breast cancer cells; MicroRNAs; Regulation

Indexed keywords

BIOLOGICAL MARKER; CYTOKERATIN 14; CYTOKERATIN 5; CYTOKERATIN 6; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MICRORNA; MICRORNA 10B; MICRORNA 146A; MICRORNA 153; MICRORNA 26A; PROGESTERONE RECEPTOR; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG; BRCA1 PROTEIN; BRCA1 PROTEIN, HUMAN; MIRN10 MICRORNA, HUMAN; MIRN146 MICRORNA, HUMAN; MIRN153 MICRORNA, HUMAN; MIRN26A MICRORNA, HUMAN; TRANSCRIPTOME; TUMOR MARKER;

3' UNTRANSLATED REGION; ALGORITHM; ARTICLE; BREAST CANCER CELL LINE; BREAST CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MCF 7 CELL LINE; MDA MB 231 CELL LINE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRIPLE NEGATIVE BREAST CANCER; TUMOR SUPPRESSOR GENE; BIOSYNTHESIS; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ALGORITHMS; BIOMARKERS, TUMOR; BRCA1 PROTEIN; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MICRORNAS; POLYMERASE CHAIN REACTION; TRANSCRIPTOME; TRANSFECTION; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84947614728     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-015-0239-3     Document Type: Article

References (44)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM.GLOBOCAN 2008 v1.2, cancer incidence and mortality worldwide: IARC cancer base no. 10 [internet]. Lyon, France: International Agency for Research on Cancer, 2010. Available from: http://globocan.iarc.fr. Accessed May 2011.
2. G. Rawat, R. Gopisetty, Thangarajan, E4BP4 is a repressor of epigenetically regulated SOSTDC1 expression in breast cancer cells. Cell. Oncol. 37, 409–419 (2014)
3. S. Wan, Y. Liu, Y. Weng, W. Wang, W. Ren, C. Fei, Y. Chen, Z. Zhang, T. Wang, J. Wang, Y. Jiang, L. Zhou, T. He, Y. Zhang, BMP9 regulates cross-talk between breast cancer cells and bone marrow-derived mesenchymal stem cells. Cell. Oncol. 37, 363–375 (2014)
4. S. Tabarestani, S.M.H. Ghaderian, H. Rezvani, R. Mirfakhraie, A. Ebrahimi, H. Attarian, J. Rafat, M. Ghadyani, H.A. Alavi, N. Kamalian, A. Rakhsha, E. Azargashb, Prognostic and predictive value of copy number alterations in invasive breast cancer as determined by multiplex ligation-dependent probe amplification. Cell. Oncol. 37, 107–118 (2014)
5. C.M. Perou, T. Sørlie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, C.A. Rees, J.R. Pollack, D.T. Ross, H. Johnsen, L.A. Akslen, O. Fluge, A. Pergamenschikov, C. Williams, S.X. Zhu, P.E. Lønning, A.L. Børresen-Dale, P.O. Brown, D. Botstein, Molecular portraits of human breast tumours. Nature 406, 747–752 (2000)
6. T. Sørlie, C.M. Perou, R. Tibshirani, T. Aas, S. Geisler, H. Johnsen, T. Hastie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, T. Thorsen, H. Quist, J.C. Matese, P.O. Brown, D. Botstein, P.E. Lønning, A.L. Børresen-Dale, Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. U. S. A. 98, 10869–10874 (2001)
7. G. Viale, L. Bottiglieri, Pathological definition of triple negative breast cancer Eur. J. Cancer 45(Suppl 1), 5–10 (2009)
8. R.R.L. Bastien, Á. Rodríguez-Lescure, M.T.W. Ebbert, A. Prat, B. Munárriz, L. Rowe, P. Miller, M. Ruiz-Borrego, D. Anderson, B. Lyons, I. Álvarez, T. Dowell, D. Wall, M.Á. Seguí, L. Barley, K.M. Boucher, E. Alba, L. Pappas, C.A. Davis, I. Aranda, C. Fauron, I.J. Stijleman, J. Palacios, A. Antón, E. Carrasco, R. Caballero, M.J. Ellis, T.O. Nielsen, C.M. Perou, M. Astill, P.S. Bernard, M. Martín, PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers. BMC Med. Genet. 5, 44 (2012)
9. R. Dent, M. Trudeau, K.I. Pritchard, W.M. Hanna, H.K. Kahn, C.A. Sawka, L.A. Lickley, E. Rawlinson, P. Sun, S.A. Narod, Triple-negative breast cancer: clinical features and patterns of recurrence. Clin. Cancer Res. 13, 4429–4434 (2007)
10. E. Yiannakopoulou, Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications. Cell. Oncol. 37, 1–8 (2014)
11. W.D. Foulkes, I.M. Stefansson, P.O. Chappuis, L.R. Bégin, J.R. Goffin, N. Wong, M. Trudel, L.A. Akslen, Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J. Natl. Cancer Inst. 95, 1482–1485 (2003)
12. C.R. Mueller, C.D. Roskelley, Regulation of BRCA1 expression and its relationship to sporadic breast cancer. Breast Cancer Res. 5, 45–52 (2003)
13. M.V. Iorio, M. Ferracin, C.-G. Liu, A. Veronese, R. Spizzo, S. Sabbioni, E. Magri, M. Pedriali, M. Fabbri, M. Campiglio, S. Ménard, J.P. Palazzo, A. Rosenberg, P. Musiani, S. Volinia, I. Nenci, G.A. Calin, P. Querzoli, M. Negrini, C.M. Croce, MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65, 7065–7070 (2005)
14. C. Salazar, R. Nagadia, P. Pandit, J. Cooper-White, N. Banerjee, N. Dimitrova, W.B. Coman, C. Punyadeera, A novel saliva-based microRNA biomarker panel to detect head and neck cancers. Cell. Oncol. 37, 331–338 (2014)
15. L. Rask, E. Balslev, R. Søkilde, E. Høgdall, H. Flyger, J. Eriksen, T. Litman, Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status. Cell. Oncol. 37, 215–227 (2014)
16. R. Nagadia, P. Pandit, W.B. Coman, J. Cooper-White, C. Punyadeera, miRNAs in head and neck cancer revisited. Cell. Oncol. 36, 1–7 (2013)
17. D.P. Bartel, MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281 (2004)
18. A.I. Garcia, M. Buisson, P. Bertrand, R. Rimokh, E. Rouleau, B.S. Lopez, R. Lidereau, I. Mikaélian, S. Mazoyer, Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers. EMBO Mol. Med. 3, 279–290 (2011)
19. M.I. Almeida, R.M. Reis, G.A. Calin, BRCA1, microRNAs and cancer predisposition: challenging the dogma. Cell Cycle 10, 377 (2011)
20. E. O’Day, A. Lal, MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res. 12, 201 (2010)
21. N.C. Turner, J.S. Reis-Filho, Basal-like breast cancer and the BRCA1 phenotype. Oncogene 25, 5846–5853 (2006)
22. N.C. Turner, J.S. Reis-Filho, A.M. Russell, R.J. Springall, K. Ryder, D. Steele, K. Savage, C.E. Gillett, F.C. Schmitt, A. Ashworth, A.N. Tutt, BRCA1 dysfunction in sporadic basal-like breast cancer. Oncogene 26, 2126–2132 (2007)
23. S. Chang, S.K. Sharan, BRCA1 and microRNAs: emerging networks and potential therapeutic targets. Mol. Cells 34, 425–432 (2012)
24. P. Moskwa, F.M. Buffa, Y. Pan, R. Panchakshari, P. Gottipati, R.J. Muschel, J. Beech, R. Kulshrestha, K. Abdelmohsen, D.M. Weinstock, M. Gorospe, A.L. Harris, T. Helleday, D. Chowdhury, miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. Mol. Cell 41, 210–220 (2011)
25. E. Kumaraswamy, K. L. Wendt, L. A. Augustine, S. R. Stecklein, E. C. Sibala, D. Li, S. Gunewardena, R. A. Jensen, BRCA1 regulation of epidermal growth factor receptor (EGFR) expression in human breast cancer cells involves microRNA-146a and is critical for its tumor suppressor function. Oncogene 34, 4333-4346 (2014)
26. F. Elstrodt, A. Hollestelle, J.H.A. Nagel, M. Gorin, M. Wasielewski, A. van den Ouweland, S.D. Merajver, S.P. Ethier, M. Schutte, BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. Cancer Res. 66, 41–45 (2006)
27. R.C. Friedman, K.K.-H. Farh, C.B. Burge, D.P. Bartel, Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92–105 (2009)
28. G.L. Papadopoulos, M. Reczko, V.A. Simossis, P. Sethupathy, A.G. Hatzigeorgiou, The database of experimentally supported targets: a functional update of TarBase. Nucleic Acids Res. 37, D155–D158 (2009)
29. D. Betel, M. Wilson, A. Gabow, D.S. Marks, C. Sander, The microRNA.org resource: targets and expression. Nucleic Acids Res. 36, D149–D153 (2008)
30. S. Griffiths-Jones, H.K. Saini, S. van Dongen, A.J. Enright, miRBase: tools for microRNA genomics. Nucleic Acids Res 36, 154–158 (2008)
31. A. Krek, D. Grün, M.N. Poy, R. Wolf, L. Rosenberg, E.J. Epstein, P. MacMenamin, I. da Piedade, K.C. Gunsalus, M. Stoffel, N. Rajewsky, Combinatorial microRNA target predictions. Nat. Genet. 37, 495–500 (2005)
32. M. Arnedos, C. Bihan, S. Delaloge, F. Andre, Triple-negative breast cancer: are we making headway at Least? Ther. Adv. Med. Oncol. 4, 195–210 (2012)
33. H. Liu, MicroRNAs in breast cancer initiation and progression. Cell. Mol. Life Sci. 69, 3587–3599 (2012)
34. X. Han, S. Yan, Z. Weijie, W. Feng, W. Liuxing, L. Mengquan, F. Qingxia, Critical role of miR-10b in transforming growth factor-β1-induced epithelial-mesenchymal transition in breast cancer. Cancer Gene Ther. 21, 60–67 (2014)
35. F. Biagioni, N. Bossel Ben-Moshe, G. Fontemaggi, V. Canu, F. Mori, B. Antoniani, A. Di Benedetto, R. Santoro, S. Germoni, F. De Angelis, A. Cambria, R. Avraham, G. Grasso, S. Strano, P. Muti, M. Mottolese, Y. Yarden, E. Domany, G. Blandino, miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours. EMBO. Mol. Med. 4, 1214–1229 (2012)
36. C.-G. Liao, L.-M. Kong, P. Zhou, X.-L. Yang, J.-G. Huang, H.-L. Zhang, N. Lu, miR-10b is overexpressed in hepatocellular carcinoma and promotes cell proliferation, migration and invasion through RhoC, uPAR and MMPs. J. Transl. Med. 12, 234 (2014)
37. G. Gabriely, N.M. Teplyuk, A.M. Krichevsky, Context effect: microRNA-10b in cancer cell proliferation, spread and death. Autophagy 7, 1384–1386 (2011)
38. J. Gao, L. Li, M. Wu, M. Liu, X. Xie, J. Guo, H. Tang, X. Xie, MiR-26a inhibits proliferation and migration of breast cancer through repression of MCL-1. PLoS One 8, e65138 (2013)
39. W. Shen, M. Song, J. Liu, G. Qiu, T. Li, Y. Hu, H. Liu, MiR-26a promotes ovarian cancer proliferation and tumorigenesis. PLoS One 9, e86871 (2014)
40. D. Bhaumik, G.K. Scott, S. Schokrpur, C.K. Patil, J. Campisi, C.C. Benz, Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene 27, 5643–5647 (2008)
41. M. Anaya-Ruiz, J. Cebada, G. Delgado-López, M. L. Sánchez-Vázquez, J. L. M. Pérez-Santos, miR-153 silencing induces apoptosis in the MDA-MB-231 breast cancer cell line. Asian Pac. J. Cancer Prev. 14, 2983–2986 (2013)
42. Z. Wu, B. He, J. He, X. Mao, Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer. Prostate 73, 596–604 (2013)
43. S. Zhao, Y. Deng, Y. Liu, X. Chen, G. Yang, Y. Mu, D. Zhang, J. Kang, Z. Wu, MicroRNA-153 is tumor suppressive in glioblastoma stem cells. Mol. Biol. Rep. 40, 2789–2798 (2013)
44. F. Bagheri, S. Safarian, M.B. Eslaminejad, N. Sheibani, siRNA-mediated knock-down of DFF45 amplifies doxorubicin therapeutic effects in breast cancer cells. Cell. Oncol. 36, 515–526 (2013)